Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial

Autor: Franck Morschhauser, Michel Henry-Amar, Richard W.M. van der Maazen, Francisca Ong, Houchingue Eghbali, Isabelle Gaillard, B. Christian, Max Beijert, Marc André, Pieternella J. Lugtenburg, Jean Gabarre, Josée Audouin, Olivier Boulat, G Tertian, Dominique Bordessoule, Philippe Hélias, Christophe Fermé, Aspasia Stamatoullas, Andrej Vranovsky, José Thomas, Judith M. Roesink, Umberto Tirelli, Daphne de Jong, Krimo Bouabdallah, Marnix L.M. Lybeert, Berthe M.P. Aleman, Hugo Gonzalez, Philippe Quittet, Evert M. Noordijk, Jérôme Jaubert, Theodore Girinsky

Publikováno v: International journal of radiation oncology, biology, physics, 100(5), 1133-1145. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 100, 5, pp. 1133-1145
Thomas, J, Fermé, C, Noordijk, E M, Morschhauser, F, Girinsky, T, Gaillard, I, Lugtenburg, P J, André, M, Lybeert, M L M, Stamatoullas, A, Beijert, M, Hélias, P, Eghbali, H, Gabarre, J, van der Maazen, R W M, Jaubert, J, Bouabdallah, K, Boulat, O, Roesink, J M, Christian, B, Ong, F, Bordessoule, D, Tertian, G, Gonzalez, H, Vranovsky, A, Quittet, P, Tirelli, U, de Jong, D, Audouin, J, Aleman, B M P & Henry-Amar, M 2018, ' Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors : Results of the EORT-GELA H9-F Intergroup Randomized Trial ', International journal of radiation oncology, biology, physics, vol. 100, no. 5, pp. 1133-1145 . https://doi.org/10.1016/j.ijrobp.2017.10.015
International Journal of Radiation Oncology Biology Physics, 100(5), 1133-1145. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 100, 1133-1145
International Journal of Radiation: Oncology-Biology-Physics, Vol. 100, p. 1133-1145 (2018)
International Journal of Radiation Oncology Biology Physics, 100(5), 1133-1145. ELSEVIER SCIENCE INC

PURPOSE: While patients with early-stage Hodgkin lymphoma (HL) have an excellent outcome with combined treatment, the radiation therapy (RT) dose and treatment with chemotherapy alone remain questionable. This noninferiority trial evaluates the feasi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333d40ec009294537c3dd25c74fc9ef8
https://doi.org/10.1016/j.ijrobp.2017.10.015

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95

Autor: Noel Milpied, Thierry Lamy, Antoine Thyss, Steven Le Gouill, Jean François Rossi, Virginie Lucas, Eric Deconinck, Bernard Desablens, Audrey Simon, Philippe Casassus, Philippe Colombat, Jean Pierre Vilque, Jérôme Jaubert, Frédéric Maloisel, Michel Peoc'h, Charles Foussard, Olivier Tournilhac, Vincent Delwail, Remy Gressin, Houchingue Eghbali

Publikováno v: British Journal of Haematology. 151:159-166

Peripheral T-Cell lymphomas (PTCL) are relatively rare diseases but appear to be highly aggressive and display worse remission and survival rates than B-cell lymphomas. Despite unsatisfactory results with the cyclophosphamide, doxorubicin, vincristin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::92cea523055b4ae5c65db7ebe645e99b
https://doi.org/10.1111/j.1365-2141.2010.08329.x

High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia

Autor: Karim Maloum, Jérôme Jaubert, Jacques Benichou, Frédéric Maloisel, Brigitte Dreyfus, Marine Divine, Pierre Feugier, Odile Guibon, Olivier Tournilhac, Philippe Travade, Charles Dumontet, Stéphane Leprêtre, Michel Leporrier, Alain Delmer, Houchingue Eghbali, Beatrice Mahe, Bruno Cazin, Xavier Leleu, Bernard Grosbois

Publikováno v: British Journal of Haematology. 143:54-59

A multicentre single-arm study testing the efficacy and toxicity of the oral combination of fludarabine and cyclophosphamide (FC) over 5 d in 75 patients with untreated B cell-chronic lymphocytic leukaemia. Oral FC demonstrated high efficacy with ove

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00e913aee04cac63dae6a730d097815
https://doi.org/10.1111/j.1365-2141.2008.07309.x

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease

Autor: Emmanuel Gyan, J.H. Meerwaldt, Chantal Rieux, Jean Gabarre, Eric Van Den Neste, Pieternella J. Lugtenburg, Pierre Lederlin, Jan Walewski, Christophe Fermé, Pauline Brice, Houchingue Eghbali, Philip Poortmans, Jacques Bosq, Michel Henry-Amar, Geert Jan Creemers, José Thomas, Christian Carrie, Patrice Carde, Oumedaly Reman, Marine Diviné, Johanna Kluin-Nelemans, Michel Blanc, Jérôme Jaubert, Gilles Salles, Anton Hagenbeek, Theodore Girinsky, Mars B. van't Veer, Françoise Berger, Joke W. Baars, Umberto Tirelli, B. Vie, John M. M. Raemaekers, Mathieu Monconduit, Fernando Viseu, Evert M. Noordijk

Publikováno v: The New England Journal of Medicine, 357, 1916-27
The New England Journal of Medicine, 357, 19, pp. 1916-27
New England Journal of Medicine, 357(19), 1916-1927. Massachussetts Medical Society
New England journal of medicine, 357(19), 1916-1927. Massachussetts Medical Society
New England Journal of Medicine, 357(19), 1916-1927. MASSACHUSETTS MEDICAL SOC

Item does not contain fulltext BACKGROUND: Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cf0f86aed2b9569e0fd3ead1f269ddd
https://doi.org/10.1056/nejmoa064601

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS

Autor: Philippe Bertrand, Vincent Delwail, Patrick Michenet, Annick Le Pourhiet-Le Mevel, Martine Escoffre-Barbe, Noel Milpied, Antoine Thyss, Remy Gressin, Jean-Pierre Vilque, Eric Legouffe, Bernard Desablens, Roselyne Delepine, Eric Deconinck, Philippe Colombat, Pascale Cornillet-Lefebvre, Jean-François Ramée, Arash Jenabian, Philippe Travade, Charles Foussard, Jérôme Jaubert, Hervé Maisonneuve

Publikováno v: Blood. 105:3817-3823

Doxorubicin-based immunochemotherapy, with interferon, has been shown to improve survival in patients with advanced follicular lymphoma. High-dose chemotherapy with stem-cell support is effective in follicular lymphoma in relapse but remains controve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ff6125bd9a1b7597e5aa2cb15f6b03
https://doi.org/10.1182/blood-2004-10-3920